Cereals as a Source of Bioactive Compounds with Anti-Hypertensive Activity and Their Intake in Times of COVID-19
- PMID: 37430980
- PMCID: PMC9601750
- DOI: 10.3390/foods11203231
Cereals as a Source of Bioactive Compounds with Anti-Hypertensive Activity and Their Intake in Times of COVID-19
Abstract
Cereals have phytochemical compounds that can diminish the incidence of chronic diseases such as hypertension. The angiotensin-converting enzyme 2 (ACE2) participates in the modulation of blood pressure and is the principal receptor of the virus SARS-CoV-2. The inhibitors of the angiotensin-converting enzyme (ACE) and the block receptors of angiotensin II regulate the expression of ACE2; thus, they could be useful in the treatment of patients infected with SARS-CoV-2. The inferior peptides from 1 to 3 kDa and the hydrophobic amino acids are the best candidates to inhibit ACE, and these compounds are present in rice, corn, wheat, oats, sorghum, and barley. In addition, the vitamins C and E, phenolic acids, and flavonoids present in cereals show a reduction in the oxidative stress involved in the pathogenesis of hypertension. The influence of ACE on hypertension and COVID-19 has turned into a primary point of control and treatment from the nutritional perspective. The objective of this work was to describe the inhibitory effect of the angiotensin-converting enzyme that the bioactive compounds present in cereals possess in order to lower blood pressure and how their consumption could be associated with reducing the virulence of COVID-19.
Keywords: COVID-19; cereals; diet therapy; drug therapy; hypertension; phytochemicals.
Conflict of interest statement
No conflict of interest among authors.
Figures



Similar articles
-
Cardiovascular Active Peptides of Marine Origin with ACE Inhibitory Activities: Potential Role as Anti-Hypertensive Drugs and in Prevention of SARS-CoV-2 Infection.Int J Mol Sci. 2020 Nov 7;21(21):8364. doi: 10.3390/ijms21218364. Int J Mol Sci. 2020. PMID: 33171852 Free PMC article. Review.
-
Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.Hypertension. 2020 Jul;76(1):51-58. doi: 10.1161/HYPERTENSIONAHA.120.15143. Epub 2020 Apr 29. Hypertension. 2020. PMID: 32348166
-
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.Intern Emerg Med. 2020 Aug;15(5):759-766. doi: 10.1007/s11739-020-02364-6. Epub 2020 May 19. Intern Emerg Med. 2020. PMID: 32430651 Free PMC article.
-
New Viral Diseases and New Possible Remedies by Means of the Pharmacology of the Renin-Angiotensin System.J Renin Angiotensin Aldosterone Syst. 2023 Jul 12;2023:3362391. doi: 10.1155/2023/3362391. eCollection 2023. J Renin Angiotensin Aldosterone Syst. 2023. PMID: 37476705 Free PMC article. Review.
-
Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries.Hypertension. 2022 Feb;79(2):365-378. doi: 10.1161/HYPERTENSIONAHA.121.18295. Epub 2021 Nov 30. Hypertension. 2022. PMID: 34844421
Cited by
-
Study of the Total Antioxidant Capacity (TAC) in Native Cereal-Pulse Flours and the Influence of the Baking Process on TAC Using a Combined Bayesian and Support Vector Machine Modeling Approach.Foods. 2023 Aug 25;12(17):3208. doi: 10.3390/foods12173208. Foods. 2023. PMID: 37685144 Free PMC article.
-
Assessing the Hypertension Risk: A Deep Dive into Cereal Consumption and Cooking Methods-Insights from China.Nutrients. 2024 Sep 8;16(17):3027. doi: 10.3390/nu16173027. Nutrients. 2024. PMID: 39275342 Free PMC article.
-
Carotenoid and Phenolic Compositions and Antioxidant Activity of 23 Cultivars of Corn Grain and Corn Husk Extract.Foods. 2024 Oct 23;13(21):3375. doi: 10.3390/foods13213375. Foods. 2024. PMID: 39517159 Free PMC article.
References
-
- Björck I., Östman E., Kristensen M., Mateo Anson N., Price R.K., Haenen G.R.M.M., Havenaar R., Bach Knudsen K.E., Frid A., Mykkänen H., et al. Cereal grains for nutrition and health benefits: Overview of results from in vitro, animal and human studies in the HEALTHGRAIN project. Trends Food Sci. Technol. 2012;25:87–100. doi: 10.1016/j.tifs.2011.11.005. - DOI
-
- Zamaratskaia G., Mhd Omar N.A., Brunius C., Hallmans G., Johansson J.-E., Andersson S.-O., Larsson A., Åman P., Landberg R. Consumption of whole grain/bran rye instead of refined wheat decrease concentrations of TNF-R2, e-selectin, and endostatin in an exploratory study in men with prostate cancer. Clin. Nutr. 2020;39:159–165. doi: 10.1016/j.clnu.2019.01.007. - DOI - PubMed
-
- Alu’Datt M.H., Ereifej K., Abu-Zaiton A., Alrababah M., Almajwal A., Rababah T., Yang W. Anti-oxidant, anti-diabetic, and anti-hypertensive effects of extracted phenolics and hydrolyzed peptides from barley protein fractions. Int. J. Food Prop. 2012;15:781–795. doi: 10.1080/10942912.2010.503357. - DOI
-
- Gupta R., Meghwal M., Prabhakar P.K. Bioactive compounds of pigmented wheat (Triticum aestivum): Potential benefits in human health. Trends Food Sci. Technol. 2021;110:240–252. doi: 10.1016/j.tifs.2021.02.003. - DOI
-
- Ho H.V.T., Sievenpiper J.L., Zurbau A., Blanco Mejia S., Jovanovski E., Au-Yeung F., Jenkins A.L., Vuksan V. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: A systematic review and meta-analysis of randomised-controlled trials. Br. J. Nutr. 2016;116:1369–1382. doi: 10.1017/S000711451600341X. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous